The next evolution of
biomanufacturing
We deliver the next generation of bioprocess technologies by leveraging the strengths of process intensification and chaining
Our Products
We design innovative cost-
effective manufacturing solutions
scale-X™ bioreactor
Intensified fixed-bed technology for
cost-effective & scalable viral production
NevoLine™ Upstream platform
Integrated & automated solution
for intensified virus manufacturing
Our Publications
Capitalize on reliable operations & technologies: start-up & assistance services
Univercells Technologies provides reliable service solutions and quality support & maintenance to help you maintain performance and maximum safety of the equipment.
Download
Intensified & automated biomanufacturing technologies for gene therapies production
The scale-X™ bioreactor range and the NevoLine™ platform: integrated and automated solutions for an intensified AAV and Lentiviral vectors manufacturing.
Download
Promising Vero cell growth in scale-X™ bioreactors
Case study comparing adherent Vero cell growth on microcarriers and intensified, fixed-bed scale-X bioreactors hydro (2.4 m²) and carbo (10-30 m²). Results demonstrate the scale-X bioreactors as a suitable alternative to traditional technologies.
Learn moreOur Company
We believe in technology
-driven affordability
Our team
Successfully leading
our innovation
Our history
Redefining biomanufacturing for human health
WE ARE HIRING
Looking For Your Next Challenge ?
Newsroom
The scale-X bioreactor is an intensified and chained bioprocessing platform for viral developers and manufacturers. It multiplies product yield and reduces operational volumes per cleanroom surface area compared to traditional technology.
Read article “scale-X™ bioreactor demonstrates superior productivity for vaccines and gene therapy”
Partnership will optimize manufacturing of extracellular vesicles (EVs) using scalable and continuous bioprocessing technologies to propel the commercialization of regenerative therapies at affordable costs.
Read article “Partnership with RoosterBio to advance scalable & continuous exosomes manufacture”